HI-164 is available for partnering: a late-stage oral therapy designed to reduce bacterial exacerbations, hospital ...
The landscape of fibrotic interstitial lung diseases (ILDs) is undergoing a significant paradigm shift. While traditionally viewed through the lens of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results